Numerous studies centering on complex interactions of glioma cells and the microenvironment have highlighted the role of two key mediators, focal adhesion kinase (FAK) [209] and the original oncogene Src [210,211], both of which participate in signaling pathways triggered by integrins or indirectly by RTKs. The gene discussed is PTK2; the disease is central nervous system cancer.